2019
DOI: 10.1039/c9ra05636j
|View full text |Cite
|
Sign up to set email alerts
|

Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: in vitro anti-proliferative and anti-invasive activity in glioblastoma

Abstract: Echinomycin, a DNA bis-intercalator peptide antibiotic, was complexed with γCD and loaded into PEGylated liposomes. The liposomes encapsulating echinomycin showed potent anti-proliferative and anti-invasive effect against U-87 MG glioblastoma cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
49
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

6
2

Authors

Journals

citations
Cited by 38 publications
(51 citation statements)
references
References 60 publications
0
49
0
Order By: Relevance
“…TEM micrographs were obtained using Morgagni (FEI, Netherlands) microscope operated at 60 kV. 29 2.6. Cellular assays 2.6.1.…”
Section: Ncl Aptamer Post-insertionmentioning
confidence: 99%
“…TEM micrographs were obtained using Morgagni (FEI, Netherlands) microscope operated at 60 kV. 29 2.6. Cellular assays 2.6.1.…”
Section: Ncl Aptamer Post-insertionmentioning
confidence: 99%
“…Aer incubation, grids were washed with distilled water and dried at room temperature before imaging with Versa 3D (FEI, Netherlands) TEM operating system at an acceleration voltage of 30 kV. 11 2.8.5. Liposomes encapsulation efficiency (EE%).…”
Section: Liposomes Preparation and Active Loadingmentioning
confidence: 99%
“…Chemical shi (d) changes, either for the host or the guest, can verify due to the formation of inclusion complex in solution. 11,46 Fig. 7 represents the chemical structure of bCD and CRM with all hydrogen atoms that may be involved in complex formation.…”
Section: H-nmr Spectroscopymentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, cancer cells may develop resistance against most cytotoxic drugs during or shortly after therapy [27,28]. Recently, a new approach was applied to support and improve traditional treatments of tumors by utilizing nano-sized-carriers to overcome the side effects [29,30], enhance the low therapeutic efficacy, and show acceptable controlled release of the drug load [31]. Additionally, fabrication of nanocarriers with targeting moieties is possible, making them selectively bind to specific receptors overexpressed in cancer cells [32,33,34].…”
Section: Introductionmentioning
confidence: 99%